Through their specific inhibition of Apicoplast DNA polymerase and Plasmodium falciparum cysteine protease, these compounds have the potential to disrupt the life cycle and metabolic pathways of Plasmodium spp., offering a novel strategy to combat drug‐resistant malaria. Here, CTSB is linked to malaria.